Marek Health vs Maximus: Coaching-Plus-Prescribing vs Fertility-Preserving Oral Protocol
Marek Health and Maximus are different shapes of differentiated TRT telehealth. Marek pairs prescribing clinicians with monthly coaching check-ins; Maximus runs a published-study fertility-preserving oral protocol. Both have imperfect BBB posture (Marek NOT Accredited with no rating; Maximus F driven by unanswered complaints). Both have small Trustpilot samples relative to cohort leaders. The choice depends on whether you want high-touch coaching cadence or protocol differentiation.
Marek Health
3.4Coaching-plus-prescribing model with lab-heavy hormone optimization
Maximus
3.1Fertility-preserving oral TRT with enclomiphene; published clinical study, but BBB F rating with unanswered complaints
Reviewed by Designing Longevity Editorial·Last verified May 1, 2026
Bottom line
Marek Health on most operational and trust dimensions. Maximus on protocol differentiation if fertility preservation is specifically what you want. Neither is the cohort default for most users (Hone Health is). For readers comparing these two specifically: Marek if monthly coaching contact between provider visits is the binding need; Maximus if the published-study fertility-preserving oral protocol is what you specifically want, with BBB caveats acknowledged.
Side-by-side at a glance
Who wins for each use case
We pick a winner per criterion and explain the reasoning. Skip to whichever rows match how you'd actually use the platform.
BBB rating and complaint posture
Winner: Marek HealthMarek is NOT BBB Accredited but has no posted letter grade (the lab-category profile is low-volume). Maximus carries a BBB F rating driven by unanswered complaints documenting repeat charges without medication delivery and refund refusals. Both are imperfect; Marek's no-rating profile is materially better than Maximus's F.
Care-model touch points between provider visits
Winner: Marek HealthMarek's defining feature is the coaching-plus-prescribing model: each patient has a named coach for monthly check-ins between provider visits. Maximus has board-certified physicians but does not market comparable monthly-coaching cadence. If high-touch contact between visits matters, Marek wins outright.
Published clinical study evidence
Winner: MaximusMaximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol (Oral T + Enclomiphene). Marek does not market a comparable published-study evidence base for its protocols.
Fertility preservation
Winner: MaximusMaximus's flagship Oral T + Enclomiphene protocol preserves LH/FSH within normal ranges by design. Marek runs traditional injectable TRT with standard LH/FSH suppression unless the prescribing clinician specifically adds ancillaries.
Trustpilot rating quality
Winner: Marek HealthMarek has 4.8/5 across roughly 430-890 reviews depending on which Trustpilot mirror you reach. Maximus has 4.4-4.6/5 across roughly 200-260 reviews. Both have clean profiles (no fraud notice), but Marek's higher rating and consistency tip this row. Both samples are smaller than cohort leaders.
All-in monthly cost
Winner: MaximusMaximus enclomiphene-only at $99.99/mo annual commitment is materially below Marek's $300-$425/mo effective with prorated lab fees. Even Maximus's Oral T + Enclomiphene at $199.99/mo annual is meaningfully cheaper than Marek. Marek's higher cost buys monthly coaching contact; the cost gap is real.
Refill and operational consistency
Winner: Marek HealthMarek's coaching cadence catches operational issues earlier in the cycle. Maximus has BBB-documented complaints including repeat charges without medication delivery, which is a structurally worse pattern than typical TRT cohort operational friction. Marek wins this row even though both have BBB imperfections.
Rubric scores side-by-side
Same six dimensions we use on every provider profile, weighted to a single 0-5 score. Click through to either profile for the verification details behind each row.
Licensure 20% weight
Accreditation 20% weight
Transparency 20% weight
Product quality 15% weight
Pricing 15% weight
Customer service 10% weight
Pricing in plain terms
Marek: $250 initial deposit + $225-$275/mo medication + $350-$700 per quarterly lab panel ($300-$425/mo effective). Maximus: $99.99/mo enclomiphene-only or $199.99/mo Oral T + Enclomiphene on annual commitment. Maximus is materially cheaper; Marek's higher cost buys monthly coaching contact between provider visits. Both are HSA/FSA eligible.
Read the full profiles
This comparison summarizes the head-to-head call. The full provider profiles include verification items, regulatory history, public-review aggregation, and the signup walkthrough.